VAMP1: Unlocking Its Potential Therapies (G6843)

Target Name: VAMP1

NCBI ID: G6843

VAMP1

VAMP1: Unlocking Its Potential Therapies

VAMP1 (CMS25) is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidneys. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells.

One of the unique features of VAMP1 is its ability to interact with other proteins, particularly with the protein p120GAP. This interaction is important for the regulation of various cellular processes, including cell signaling, DNA replication, and apoptosis.

In addition to its role in cellular signaling, VAMP1 has also been shown to play a key role in the development and progression of a variety of diseases, including cancer. For example, studies have shown that VAMP1 is overexpressed in various types of cancer, and that this overexpression is associated with unfavorable clinical outcomes.

Despite these promising findings, much more research is needed about the role of VAMP1 in cancer progression and the development of new therapeutic approaches. One potential avenue for research is the use of small molecules as drugs that target VAMP1.

One such small molecule is called NXJ218, which is a compound that was developed by the company Natera. NXJ218 is designed to bind to a specific epitope on the surface of VAMP1, and has been shown to inhibit the activity of this protein in cell culture models.

Another potential small molecule that may target VAMP1 is called SM301, which is also being developed by Natera. SM301 is a peptide that is derived from a portion of the VAMP1 protein and has been shown to have activity against VAMP1 in cell culture models.

While the use of small molecules like NXJ218 and SM301 as drugs that target VAMP1 is an exciting area of research, there are also other potential approaches that could be explored. For example, one approach could be to use antibodies to target VAMP1 and remove it from cells, which could be done using techniques such as affinity purification or adsorption.

Another potential approach could be to use small molecules or other compounds that specifically interact with VAMP1 to alter its activity. For example, one could use small molecules to regulate the levels of VAMP1 in cells, or to alter the structure and function of the protein itself.

Overall, the role of VAMP1 in cellular signaling and disease progression is an area of great interest, and there are many potential approaches that could be explored to further our understanding of this protein and its role in disease. Further research is needed to determine the full extent of VAMP1's involvement in these processes, and to develop new therapeutic approaches that can target this protein and improve the health and well-being of individuals with cancer and other diseases.

Protein Name: Vesicle Associated Membrane Protein 1

Functions: Involved in the targeting and/or fusion of transport vesicles to their target membrane

The "VAMP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VAMP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets